BriaCell Therapeutics (BCTXW) Competitors $0.08 -0.02 (-20.49%) As of 04/17/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BCTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, CELUW, and CINGWShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. BriaCell Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and BriaCell Therapeutics (NASDAQ:BCTXW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings. Is ATNFW or BCTXW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A BriaCell Therapeutics N/A N/A N/A Which has better valuation and earnings, ATNFW or BCTXW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ABriaCell TherapeuticsN/AN/AN/AN/AN/A Does the MarketBeat Community believe in ATNFW or BCTXW? 180 Life Sciences and BriaCell Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ABriaCell TherapeuticsN/AN/A Does the media prefer ATNFW or BCTXW? In the previous week, BriaCell Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for BriaCell Therapeutics and 0 mentions for 180 Life Sciences. BriaCell Therapeutics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that BriaCell Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral BriaCell Therapeutics Positive SummaryBriaCell Therapeutics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTXW vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$122.22M$5.31B$7.35BDividend YieldN/A3.82%5.47%4.31%P/E RatioN/A3.0521.9417.82Price / SalesN/A4,230.36380.9497.72Price / CashN/A13.2238.3134.64Price / BookN/A34.746.453.98Net IncomeN/A-$93.04M$3.22B$247.81M7 Day PerformanceN/A2.19%5.85%3.19%1 Month PerformanceN/A-5.51%-9.58%-7.70%1 Year PerformanceN/A85.44%11.85%1.49% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXWBriaCell TherapeuticsN/A$0.06-32.2%N/A-93.1%$0.00N/A0.008Positive NewsGap UpATNFW180 Life SciencesN/A$0.01-2.5%N/A-12.2%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02-15.8%N/A-80.5%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.09+10.4%N/A+97.8%$0.00$20,729.000.0040Positive NewsGap UpALVOWAlvotechN/A$1.30-13.9%N/A-68.4%$0.00$489.68M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.07+30.5%N/AN/A$0.00$37.32M0.0070Positive NewsGap UpBTMDWbioteN/A$0.03+17.0%N/AN/A$0.00$197.19M0.00N/AGap DownCELUWCelularityN/A$0.04+1.9%N/A+1.0%$0.00$48.20M0.00220Positive NewsCINGWCingulateN/A$0.04-7.5%N/A+198.7%$0.00N/A0.0020Positive News Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTXW) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTXW Stock Free BCTXW Stock Alerts